Ryali Sriram
Caribou Biosciences, Inc. · Chief Financial Officer
Ryali Sriram is listed in filings as Chief Financial Officer at Caribou Biosciences, Inc.. This profile follows SEC Form 4 activity through Feb 20, 2026, including purchase activity. Recent filings connect the profile to Caribou Biosciences, Inc. (CRBU). The current snapshot covers public activity from Jan 10, 2025 to Feb 20, 2026. Reported amounts are shown as $445.5K to $492.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||